4D Molecular Therapeutics, Inc.
FDMT
$10.45
$0.111.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -160.90M | -140.11M | -209.18M | -196.14M | -176.44M |
| Total Depreciation and Amortization | 7.93M | 7.63M | 7.43M | 7.13M | 6.87M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.93M | 17.23M | 18.55M | 19.46M | 19.43M |
| Change in Net Operating Assets | 8.59M | 6.17M | -301.00K | 3.16M | -3.11M |
| Cash from Operations | -129.45M | -109.08M | -183.50M | -166.39M | -153.26M |
| Capital Expenditure | 95.00K | -536.00K | -1.56M | -3.42M | -3.71M |
| Sale of Property, Plant, and Equipment | 11.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.14M | -92.44M | 44.49M | 55.88M | -3.52M |
| Cash from Investing | -56.03M | -92.97M | 42.93M | 52.46M | -7.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 124.44M | 112.96M | 1.58M | 2.03M | 18.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 124.44M | 112.96M | 1.58M | 2.03M | 18.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.04M | -89.10M | -138.98M | -111.90M | -142.07M |